Quantcast
Last updated on April 19, 2014 at 13:20 EDT

Latest Nissen fundoplication Stories

2014-03-20 12:33:35

BETHESDA, Md., March, 20, 2014 /PRNewswire-USNewswire/ -- The American Gastroenterological Association (AGA) Center for GI Innovation and Technology today announced a partnership with EndoGastric Solutions® to develop a registry comparing surgery to an incisionless procedure to treat gastroesophageal reflux disease (GERD). The "STAR Registry" (Laparoscopic Nissen Fundoplication (LNF) Surgery Versus Transoral Incisionless Fundoplication (TIF®): Anti- Reflux Treatment Registry) will...

2014-03-19 08:28:57

OMER, Israel, March 19, 2014 /PRNewswire/ -- Medigus Ltd. (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and procedures announced today that two oral presentations will highlight the MUSE(TM) System at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) annual meeting, taking place April 2 - 5, 2014 at the Salt Palace Convention Center, Salt Lake City, Utah. Medigus is exhibiting at booth # 1113....

2014-03-07 08:25:45

DUBLIN, Mar. 07, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/zth6xm/operations_on_the ) has announced the addition of the "Concise Analysis of the European Operations on the Digestive System Market - Surgical Procedure Volumes" directory to their offering. (Logo:http://photos.prnewswire.com/prnh/20130307/600769) 'Concise Analysis of the European Operations on the Digestive System Market - Surgical Procedure Volumes' includes procedure numbers...

2014-02-12 04:21:03

-MUSE(TM) offers millions of patients with reflux durable relief and the potential to eliminate the use of lifelong medication helping reduce healthcare costs- OMER, Israel, Feb. 12, 2014 /PRNewswire/ -- Medigus Ltd. (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and procedures, reveals additional details regarding its commercial strategy, including rebranding its flagship product MUSE(TM), formerly the SRS System. Through this strategy, CEO Chris...

2014-01-07 12:29:02

OMER, Israel, Jan. 7, 2014 /PRNewswire/ -- Medigus Ltd. (TASE: MDGS) announced today that Mr. Chris Rowland, CEO, will present at the 16(th) Annual Needham Growth Conference taking place at The New York Palace Hotel in New York City January 14 - 16, 2014. Mr. Rowland's presentation is scheduled for Wednesday, January 15, 2014 at 12:05 p.m. EST. To access a live webcast of this presentation, visit http://wsw.com/webcast/needham64/mdgs.ta. An archived recording will also be available...

2013-07-23 08:26:24

BETHESDA, Md., July 23, 2013 /PRNewswire-USNewswire/ -- New treatment guidelines on the diagnosis and management of achalasia, a primary motor disorder of the esophagus, appear in the August issue of The American Journal of Gastroenterology. The updated guidelines from the American College of Gastroenterology include an overview of the disease and highlight new recommendations for its diagnosis and management, based on evidence-quality evaluations in patients with achalasia, as well...

2013-05-19 08:20:16

Non-Surgical Procedure Yields High Patient Satisfaction Scores; Reduced Need for Medication; No Serious Adverse Effects ORLANDO, Fla., May 19, 2013 /PRNewswire/ -- The non-surgical Stretta® procedure employing low power and low temperature radiofrequency (RF) energy is effective in control of gastroesophageal reflux disease (GERD), and eliminates or reduces the need for medication 10 years post-procedure, according to an independent, prospective long-term assessment presented...

2013-05-16 12:31:06

OMER, Israel, May 16, 2013 /PRNewswire/ -- Medigus Ltd. (TASE:MDGS), a leading medical device company dedicated to the development of innovative endoscopic procedures and technologies, will be presenting the successful three year follow-up data of the SRS(TM) pivotal study at the Digestive Disease Week in Orlando on May 18-21st 2013. (Logo: http://photos.prnewswire.com/prnh/20130313/601331 ) The study that was conducted in Indiana University, a leading U.S...

2013-02-21 08:30:44

ST. PAUL, Minn., Feb. 21, 2013 /PRNewswire/ -- For the millions who suffer from Gastroesophageal Reflux Disease (GERD), a study published today in the New England Journal of Medicine (NEJM) provides clinical evidence of safety and effectiveness for a new, FDA-approved medical device. Torax Medical's LINX(®) Reflux Management System was studied in a controlled, prospective, multicenter trial involving 14 U.S. and European medical centers as part of the FDA pre-market approval process....

2013-02-05 20:21:06

Northwestern Medicine experts are the first in Illinois to offer new GERD procedure CHICAGO, Feb. 5, 2013 /PRNewswire-USNewswire/ -- Affecting one in every four Americans, gastroesophageal reflux disease (GERD) is the most prevalent gastrointestinal disease in the United States. Very little has changed in the treatment of this condition over the last several decades, until now. Last year, a new device to help treat GERD, called the LINX Reflux Management System was approved after four...